At Maks BioSolutions, we are dedicated to improving patient outcomes through the supply of high-quality plasma-derived therapies across the GCC and MENA regions. With a focus on Immunoglobulin (IVIG) and Human Albumin, we are a trusted partner to healthcare providers, ministries, and procurement authorities.
We specialize in bridging the gap between global pharmaceutical manufacturers and regional healthcare systems, ensuring every product delivered meets the highest standards of efficacy, safety, and compliance.
We are experts in navigating regulatory frameworks, ensuring full SFDA registration, NUPCO compliance, and audit-ready .
Our longstanding relationship with Saudi Arabia’s centralized procurement body reflects our reliability and regulatory strength in public tenders.
To ensure consistent access to life-saving plasma products with excellence in regulatory compliance, product quality, and healthcare logistics.
Please reach out to us regarding your questions or anything.
Answers to common questions about our products, services, and regulatory support across the GCC and MENA regions.
We specialize in Immunoglobulin (IVIG) and Human Albumin (5% and 20%), both essential in critical care, immune deficiencies, liver disease, and surgical recovery.
Yes. All products are SFDA-registered and supplied through NUPCO-approved channels. We ensure full regulatory compliance and documentation with every shipment.
Absolutely. We are experts in regulatory affairs, covering product registration, import licensing, and post-market surveillance for GCC and MENA regions.
We have been supplying plasma products through NUPCO tenders since 2020, making us a trusted and experienced vendor for Saudi Arabia’s central procurement and logistics hub. Our products are pre-approved and regularly delivered under national frameworks.